Creative Planning’s Evoke Pharma EVOK Stock Holding History

Creative Planning’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-694	Closed	-$183K	–	2232
2021 Q1	$183K	Hold	694	–	–	﹤0.01%	2123
2020 Q4	$258K	Hold	694	–	–	﹤0.01%	1713
2020 Q3	$469K	Hold	694	–	–	﹤0.01%	1168
2020 Q2	$354K	Hold	694	–	–	﹤0.01%	1214
2020 Q1	$116K	Hold	694	–	–	﹤0.01%	1498
2019 Q4	$162K	Hold	694	–	–	﹤0.01%	1680
2019 Q3	$86K	Hold	694	–	–	﹤0.01%	1734
2019 Q2	$63K	Hold	694	–	–	﹤0.01%	1795
2019 Q1	$150K	Hold	694	–	–	﹤0.01%	1637
2018 Q4	$248K	Hold	694	–	–	﹤0.01%	1346
2018 Q3	$298K	Hold	694	–	–	﹤0.01%	1400
2018 Q2	$250K	Hold	694	–	–	﹤0.01%	1483
2018 Q1	$208K	Hold	694	–	–	﹤0.01%	1586
2017 Q4	$226K	Buy	+694	New	+$288K	﹤0.01%	1520

Other funds holding EVOK

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Creative Planning's EVOK Position: Q2 2021 in Review

Creative Planning sold out of Evoke Pharma (EVOK) in Q2 2021, closing a stake of 694 shares — an estimated $183K sold.

Creative Planning first reported a position in EVOK in Q4 2017 and held it in 14 quarters. The position peaked at $469K in Q3 2020. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2021.

Creative Planning reported no remaining Evoke Pharma position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 694 Evoke Pharma shares in Q2 2021, an estimated $183K.
Creative Planning first reported a position in Evoke Pharma in Q4 2017 and held it in 14 quarters.
Creative Planning's Evoke Pharma position peaked at $469K in Q3 2020.
19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.